Biomedical Engineering Reference
In-Depth Information
89. Wattanakrai P, Mornchan R, Eimpunth S. Low-fl uence Q-switched neo-
dymium-doped yttrium aluminum garnet (1,064 nm) laser for the treat-
ment of facial melasma in Asians. Dermatol Surg 2010; 36: 76-87.
90. Cho SB, Kim JS, Kim MJ. Melasma treatment in Korean women using a
1064-nm Q-switched Nd:YAG laser with low pulse energy. Clin Exp
Dermatol 2009; 34: e847-50.
91. Chan NP, Ho SG, Shek SY, et al. A case series of facial depigmentation
associated with low fl uence Q-switched 1,064 nm Nd:YAG laser for skin
rejuvenation and melasma. Lasers Surg Med 2010; 42: 712-19.
92. Kim MJ, Kim JS, Cho SB. Punctate leucoderma after melasma treatment
using 1064-nm Q-switched Nd:YAG laser with low pulse energy. J Eur
Acad Dermatol Venereol 2009; 23: 960-2.
93. Manaloto RMP, Alster T. Laser resurfacing for refractory melasma. Der-
matol Surg 1999; 25: 121-3.
94. Polnikorn N, Goldberg DJ, Suwanchinda A, et al. Erbium:YAG laser
resurfacing in Asians. Dermatol Surg 1998; 24: 1303-7.
95. Angsuwarangsee S, Polnikorn N. Combined ultrapulse CO
2
laser and
Q-switched alexandrite laser compared with Q-switched alexandrite
laser alone for refractory melasma: split-face design. Dermatol Surg
2003; 29: 59-64.
96. Nouri K, Bowes L, Chartier T, et al. Combination treatment of melasma
with pulsed CO
2
laser followed by Q-switched alexandrite laser: a pilot
study. Dermatol Surg 1999; 25: 494-7.
97. Minwalla L, Zhao Y, Le Poole IC, et al. Keratinocytes play a role in regu-
lating distribution patterns of recipient melanosomes in vitro. J Invest
Dermatol 2001; 117: 341-7.
98. Seiberg M. Keratinocyte-melanocyte interactions during melanosome
transfer. Pigment Cell Res 2001; 14: 236-42.
99. Wanitphakdeedecha R, Manuskiatti W, Siriphukpong S, et al. Treatment
of melasma using variable square pulse Er:YAG laser resurfacing.
Dermatol Surg 2009; 35: 475-81; discussion 81-2.
100. Katz TM, Glaich AS, Goldberg LH, et al. Treatment of melasma using
fractional photothermolysis: a report of eight cases with long-term
follow-up. Dermatol Surg 2010; 36: 1273-80.
101. Lee HS, Won CH, Lee DH, et al. Treatment of melasma in Asian skin
using a fractional 1,550-nm laser: an open clinical study. Dermatol Surg
2009; 35: 1499-504.
102. Rokhsar CK, Fitzpatrick RE. The treatment of melasma with fractional
photothermolysis: a pilot study. Dermatol Surg 2005; 31: 1645-50.
103. Sherling M, Friedman PM, Adrian R, et al. Consensus recommendations
on the use of an erbium-doped 1,550-nm fractionated laser and its appli-
cations in dermatologic laser surgery. Dermatol Surg 2010; 36: 461-9.
104. Hantash BM, Bedi VP, Sudireddy V, et al. Laser-induced transepidermal
elimination of dermal content by fractional photothermolysis. J Biomed
Opt 2006; 11: 041115.
105. Naito SK. Fractional photothermolysis treatment for resistant melasma
in Chinese females. J Cosmet Laser Ther 2007; 9: 161-3.
106. Wind BS, Kroon MW, Meesters AA, et al. Non-ablative 1,550 nm frac-
tional laser therapy versus triple topical therapy for the treatment of
melasma: a randomized controlled split-face study. Lasers Surg Med
2010; 42: 607-12.
107. Karsai S, Fischer T, Pohl L, et al. Is non-ablative 1550-nm fractional pho-
tothermolysis an effective modality to treat melasma? Results from a
prospective controlled single-blinded trial in 51 patients. J Eur Acad
Dermatol Venereol 2012; 26: 470-6.
108. Hidano A, Kajima H, Ikedea S, et al. Natural history of nevus of Ota.
Arch Dermatol 1967; 95: 187-95.
109. Halasa A. Malignant melanoma in a case of bilateral nevus of Ota. Arch
Ophthalmol 1970; 84: 176-8.
110. Sang DN, Albert SM, Sober AJ. Nevus of Ota with contralateral cerebral
melanoma. Arch Ophthalmol 1977; 95: 1820-4.
111. Geronemus RG. Q-switched ruby laser therapy of nevus of Ota. Arch
Dermatol 1992; 128: 1618-22.
112. Taylor CR, Flotte TJ, Gange RW, et al. Treatment of nevus of Ota by
Q-switched ruby laser. J Am Acad Dermatol 1994; 30: 743-51.
113. Watanabe S, Takahashi H. Treatment of nevus of Ota with the Q-switched
ruby laser. N Engl J Med 1994; 331: 1745-50.
114. Alster TS, Williams CM. Treatment of nevus of Ota by the Q-switched
alexandrite laser. Dermatol Surg 1995; 21: 592-6.
115. Kang W, Lee E, Choi GS. Treatment of Ota's nevus by Q-switched alex-
andrite laser: therapeutic outcome in relation to clinical and histopatho-
logical fi ndings. Eur J Dermatol 1999; 9: 639-43.
116. Suh DH, Hwang JH, Lee HS, et al. Clinical features of Ota's naevus in
Koreans and its treatment with Q-switched alexandrite laser. Clin Exp
Dermatol 2000; 25: 269-73.
117. Wang HW, Liu YH, Zhang GK, et al. Analysis of 602 Chinese cases of
nevus of Ota and the treatment results treated by Q-switched alexan-
drite laser. Dermatol Surg 2007; 33: 455-60.
118. Chan HH, King WW, Chan ES, et al. In vivo trial comparing patients'
tolerance of Q-switched Alexandrite (QS Alex) and Q-switched
neodymium:yttrium-aluminum-garnet (QS Nd:YAG) lasers in the
treatment of nevus of Ota. Lasers Surg Med 1999; 24: 24-8.
119. Ueda S, Isoda M, Imayama S. Response of naevus of Ota to Q-switched
ruby laser treatment according to lesion colour. Br J Dermatol 2000; 142:
77-83.
120. Kono T, Nozaki M, Chan HH, et al. A retrospective study looking at the
long-term complications of Q-switched ruby laser in the treatment of
nevus of Ota. Lasers Surg Med 2001; 29: 156-9.
121. Kono T, Chan HH, Ercocen AR, et al. Use of Q-switched ruby laser in the
treatment of nevus of Ota in different age groups. Lasers Surg Med 2003;
32: 391-5.
122. Teekhasaenee C, Ritch R, Rutnin U, et al. Glaucoma in oculodermal
melanocytosis. Ophthalmology 1990; 97: 562-70.
123. Sun CC, Lu YC, Lee EF, et al. Naevus fusco-caeruleus zygomaticus. Br J
Dermatol 1987; 117: 545-53.
124. Manuskiatti W, Eimpunth S, Wanitphakdeedecha R. Effect of cold air
cooling on the incidence of postinfl ammatory hyperpigmentation after
Q-switched Nd:YAG laser treatment of acquired bilateral nevus of Ota
like macules. Arch Dermatol 2007; 143: 1139-43.
125. Kunachak S, Leelaudomlipi P, Sirikulchayanonta V. Q-Switched ruby
laser therapy of acquired bilateral nevus of Ota-like macules. Dermatol
Surg 1999; 25: 938-41.
126. Manuskiatti W, Sivayathorn A, Leelaudomlipi P, et al. Treatment of
acquired bilateral nevus of Ota-like macules (Hori's nevus) using a com-
bination of scanned carbon dioxide laser followed by Q-switched ruby
laser. J Am Acad Dermatol 2003; 48: 584-91.
127. Lam AY, Wong DS, Lam LK, et al. A retrospective study on the effi cacy
and complications of Q-switched alexandrite laser in the treatment of
acquired bilateral nevus of Ota-like macules. Dermatol Surg 2001; 27:
937-41; discussion 41-2.
128. Kunachak S, Leelaudomlipi P. Q-switched Nd:YAG laser treatment for
acquired bilateral nevus of Ota-like maculae: a long-term follow-up.
Lasers Surg Med 2000; 26: 376-9.
129. Polnikorn N, Tanrattanakorn S, Goldberg DJ. Treatment of Hori's
nevus with the Q-switched Nd:YAG laser. Dermatol Surg 2000; 26:
477-80.
130. Suh DH, Han KH, Chung JH. Clinical use of the Q-switched Nd:YAG
laser for the treatment of acquired bilateral nevus of Ota-like macules
(ABNOMs) in Koreans. J Dermatolog Treat 2001; 12: 163-6.
131. Ee HL, Goh CL, Khoo LS, et al. Treatment of acquired bilateral nevus
of ota-like macules (Hori's nevus) with a combination of the 532 nm
Q-Switched Nd:YAG laser followed by the 1,064 nm Q-switched
Nd:YAG is more effective: prospective study. Dermatol Surg 2006; 32:
34-40.
132. Kopera D, Hohenleutner U, Landthaler M. Quality-switched ruby laser
treatment of solar lentigines and Becker's nevus: a histopathological and
immunohistochemical study. Dermatology 1997; 194: 338-43.
133. Grevelink JM, Gonzalez S, Bonoan R, et al. Treatment of nevus spilus with
the Q-switched ruby laser. Dermatol Surg 1997; 23: 365-9; discussion
69-70.
134. Milgraum SS, Cohen ME, Auletta MJ. Treatment of blue nevi with the
Q-switched ruby laser. J Am Acad Dermatol 1995; 32: 307-10.
135. Duke D, Byers HR, Sober AJ, et al. Treatment of benign and atypical nevi
with the normal-mode ruby laser and the Q-switched ruby laser: clinical
improvement but failure to completely eliminate nevomelanocytes. Arch
Dermatol 1999; 135: 290-6.
136. Grevelink JM, van Leeuwen RL, Anderson RR, et al. Clinical and histo-
logical responses of congenital melanocytic nevi after single treatment
with Q-switched lasers. Arch Dermatol 1997; 133: 349-53.
137. Nelson JS, Kelly KM. Q-Switched ruby laser treatment of a congenital
melanocytic nevus. Dermatol Surg 1999; 25: 274-6.
138. Vibhagool C, Byers HR, Grevelink JM. Treatment of small nevomelano-
cytic nevi with a Q-switched ruby laser. J Am Acad Dermatol 1997; 36:
738-41.
